Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Bifidobacterium adolescentis is a probiotic bacterium that is naturally present in the human gastrointestinal tract, including the small intestine. While it is more abundant in the colon, some studies have identified its presence and potential activity in the small intestine. The use of B. adolescentis to support small intestinal health is primarily based on its general probiotic properties, such as modulation of the gut microbiota, production of short-chain fatty acids, and competition with pathogenic microbes. Some research suggests that B. adolescentis can help reduce inflammation and improve gut barrier function, which are relevant to small intestinal health.

However, direct evidence specifically supporting the use of B. adolescentis for small intestine health is limited. Most clinical studies have focused on broader gastrointestinal benefits, such as alleviation of symptoms in irritable bowel syndrome (IBS) and support for general gut health. A few in vitro and animal studies suggest potential benefits for the small intestine, such as influencing intestinal permeability and modulating immune responses, but human data are sparse.

In summary, while there is some scientific rationale and preliminary evidence for the use of B. adolescentis to support the small intestine, the strength of evidence is low. More targeted clinical research is required to establish a clear benefit for this specific body system.

More about Bifidobacterium adolescentis
More about Small Intestines

Other ingredients that support Small Intestines

Other body systems supported by Bifidobacterium adolescentis

Products containing Bifidobacterium adolescentis